These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8434807)

  • 1. New approaches in the medical management of venous ulceration.
    Colgan MP; Moore DJ; Shanik DG
    Angiology; 1993 Feb; 44(2):138-42. PubMed ID: 8434807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatments for venous leg ulcers.
    Renton EJ
    J Wound Care; 1999 Apr; 8(4):195-7. PubMed ID: 10455635
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver enzymes and lipid levels in patients with lipodermatosclerosis and venous ulcers treated with a prototypic anabolic steroid (stanozolol): a prospective, randomized, double-blinded, placebo-controlled trial.
    Carson P; Hong CJ; Otero-Vinas M; Arsenault EF; Falanga V
    Int J Low Extrem Wounds; 2015 Mar; 14(1):11-8. PubMed ID: 25652757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of venous ulcers.
    Falanga V; Eaglstein WH
    Am Fam Physician; 1986 Feb; 33(2):274-81. PubMed ID: 2936224
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of combined treatment for venous ulcers in postphlebitic syndrome and use of PGE-1--introductory remarks].
    Lazarkiewicz B; Winowski J; Zwoliński K; Kamiński R; Anil KA; Milan M; Skalski A; Ahmed K
    Wiad Lek; 1997; 50 Suppl 1 Pt 2():65-8. PubMed ID: 9424929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon.
    Frick RW
    Angiology; 2000 Mar; 51(3):197-205. PubMed ID: 10744007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does stanozolol prevent venous ulceration?
    Drug Ther Bull; 1985 Nov; 23(23):91-2. PubMed ID: 3905324
    [No Abstract]   [Full Text] [Related]  

  • 8. [Usefulness of pentoxifylline in the therapy of venous and mixed dystrophic ulcers of the legs].
    Galbiati G; Carnovali M
    G Ital Dermatol Venereol; 1987 Apr; 122(4):XXI-XXIV. PubMed ID: 3610219
    [No Abstract]   [Full Text] [Related]  

  • 9. Pentoxifylline--efficient in the treatment of venous ulcers in the absence of compression?
    Nikolovska S; Pavlova L; Petrova N; Gocev G; Ivanovski M
    Acta Dermatovenerol Croat; 2002 Mar; 10(1):9-13. PubMed ID: 12137725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline for leg ulcers.
    Jull A
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):440. PubMed ID: 15749046
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of venous ulcers with pentoxifylline: a 6-month randomized, double-blind, placebo controlled trial.
    Belcaro G; Cesarone MR; Nicolaides AN; De Sanctis MT; Incandela L; Geroulakos G
    Angiology; 2002; 53 Suppl 1():S45-7. PubMed ID: 11865836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroven in the treatment of chronic venous insufficiency.
    Pulvertaft TB
    Practitioner; 1979 Dec; 223(1338):838-41. PubMed ID: 396527
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic venous disorders - necessity of specific differentiation to determination of the best medical treatment].
    Karetová D
    Vnitr Lek; 2015 Sep; 61(9):762-4. PubMed ID: 26790171
    [No Abstract]   [Full Text] [Related]  

  • 14. Micronized diosmin (Detralex) for vein-related trophic ulcers: European experience.
    Savel'ev VS; Pokrovskiĭ AV; Sapelkin SV; Bogachev VIu; Bogdanets LI; Zolotukhin IA
    Angiol Sosud Khir; 2006; 12(3):53-60. PubMed ID: 17641615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological agents in the treatment of venous disease: an update of the available evidence.
    Gohel MS; Davies AH
    Curr Vasc Pharmacol; 2009 Jul; 7(3):303-8. PubMed ID: 19601855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of venous ulcers with pentoxifylline: a 12-month, double-blind, placebo controlled trial. Microcirculation and healing.
    De Sanctis MT; Belcaro G; Cesarone MR; Ippolito E; Nicolaides AN; Incandela L; Geroulakos G
    Angiology; 2002; 53 Suppl 1():S49-51. PubMed ID: 11865837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral pentoxifylline therapy on venous lower extremity ulcers due to deep venous incompetence.
    Angelides NS; Weil von der Ahe CA
    Angiology; 1989 Aug; 40(8):752-63. PubMed ID: 2604770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency.
    Roztocil K; Stvrtinová V; Strejcek J
    Int Angiol; 2003 Mar; 22(1):24-31. PubMed ID: 12771852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous ulcers: pathophysiology and treatment options.
    Trent JT; Falabella A; Eaglstein WH; Kirsner RS
    Ostomy Wound Manage; 2005 May; 51(5):38-54; quiz 55-6. PubMed ID: 16014984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daflon 500 mg and venous leg ulcer: new results from a meta-analysis.
    Smith PC
    Angiology; 2005; 56 Suppl 1():S33-9. PubMed ID: 16193225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.